{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:37:37Z","timestamp":1784367457881,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.euroneuro.2003.09.003","type":"journal-article","created":{"date-parts":[[2003,11,24]],"date-time":"2003-11-24T14:09:05Z","timestamp":1069682945000},"page":"267-273","source":"Crossref","is-referenced-by-count":109,"title":["Elevation of the cortisol\/dehydroepiandrosterone ratio in schizophrenia patients"],"prefix":"10.1016","volume":"14","author":[{"given":"Michael","family":"Ritsner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Maayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoly","family":"Gibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rael D","family":"Strous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Modai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2003.09.003_BIB1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00060793-200006000-00010","article-title":"Dehydroepiandrosterone sulfate and dehydroepiandrosterone: neuroactive neurosteroids","volume":"7","author":"Akwa","year":"2000","journal-title":"Curr. Opin. Endocrinol. Diabetes"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/07435800009048561","article-title":"DHEA replacement in women with adrenal insufficiency-pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition","volume":"26","author":"Arlt","year":"2000","journal-title":"Endocr. Res."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0091-3057(98)00188-9","article-title":"Antipsychotic drugs and reproductive hormones: relationship to body weight regulation","volume":"62","author":"Baptista","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB4","first-page":"S221","article-title":"Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids","volume":"150","author":"Baulieu","year":"1996","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB5","first-page":"139","article-title":"Study of the stress response: role of anxiety, cortisol and DHEA-S","volume":"28","author":"Boudarene","year":"2002","journal-title":"Encephale"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB6","first-page":"583","article-title":"Cortisol, estradiol, and androgens in acutely ill paranoid schizophrenics","volume":"18","author":"Brophy","year":"1983","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1525-1373.1999.d01-124.x","article-title":"Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action","volume":"222","author":"Cardounel","year":"1999","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB8","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1073\/pnas.78.8.4704","article-title":"Characterization and measurement of dehydroepiandrosterone sulfate in rat brain","volume":"78","author":"Corpechot","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB9","series-title":"The Brief Symptom Inventory (BSI): Administration, Scoring and Procedures Manual","author":"Derogatis","year":"1982"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB10","doi-asserted-by":"crossref","first-page":"13925","DOI":"10.1073\/pnas.240269897","article-title":"Gamma-aminobutyric acid, acting through gamma-aminobutyric acid type A receptors, inhibits the biosynthesis of neurosteroids in the frog hypothalamus","volume":"97","author":"Do-Rego","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/jcem-52-2-181","article-title":"Discrimination between schizophrenic and control subjects by means of plasma dehydroepiandrosterone measurements","volume":"52","author":"Erb","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB12","series-title":"SCID (DSM-IV). Structured Clinical Interview for Axis I DSM-IV Disorders\u2014Patient Edition (SCID-I\/P)","author":"First","year":"1995"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB13","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1073\/pnas.89.5.1567","article-title":"Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it","volume":"89","author":"Flood","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S0033291700034644","article-title":"Adrenal secretion during major depression in 8- to 16-year-olds, I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation","volume":"26","author":"Goodyer","year":"1996","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/15622970109027500","article-title":"Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients","volume":"2","author":"Harris","year":"2001","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0306-9877(97)90258-9","article-title":"Relationship of dehydroepiandrosterone and cortisol in disease","volume":"49","author":"Hechter","year":"1997","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB17","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1210\/jc.83.9.3130","article-title":"Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients","volume":"83","author":"Heuser","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-3223(99)00217-6","article-title":"DHEA-S plasma levels and incidence of Alzheimer's disease","volume":"47","author":"Hillen","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB19","unstructured":"Hintze, J.L., 1998. NCSS 6.0. Statistical System for Windows. User's Guide. Number Cruncher Statistical Systems, Kaysville UT."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0006-2952(99)00385-8","article-title":"Anti-stress effects of dehydroepiandrosterone: protection of rats against repeated immobilization stress-induced weight loss, glucocorticoid receptor production, and lipid peroxidation","volume":"59","author":"Hu","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000026493","article-title":"Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia","volume":"37","author":"Jakovljevic","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0920-9964(98)00066-8","article-title":"Blunted cortisol response to a psychosocial stressor in schizophrenia","volume":"33","author":"Jansen","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002130000381","article-title":"Selective impairments in the stress response in schizophrenic patients","volume":"149","author":"Jansen","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0047-6374(01)00369-4","article-title":"Uses of DHEA in aging and other disease states","volume":"1","author":"Johnson","year":"2002","journal-title":"Aging Res. Rev."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB26","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1073\/pnas.95.4.1852","article-title":"Dehydroepiandrosterone (DHEA) and DHEA-Sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity","volume":"95","author":"Kimonides","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0306-4522(98)00347-9","article-title":"Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures","volume":"89","author":"Kimonides","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/00912709922007903","article-title":"DHEA and DHEA-S: a review","volume":"39","author":"Kroboth","year":"1999","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB29","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.82.8.2396","article-title":"Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging","volume":"82","author":"Labrie","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0006-3223(95)00065-8","article-title":"Combined dexamethasone\/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II","volume":"38","author":"Lammers","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB69","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0074-7742(01)46069-7","article-title":"Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases","volume":"46","author":"Lapchak","year":"2001","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0006-3223(00)00848-9","article-title":"Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients","volume":"48","author":"Maayan","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0301-0082(92)90025-A","article-title":"Neurosteroids: endogenous bimodal modulators of the GABAa receptor. Mechanisms of action and physiological significance","volume":"38","author":"Majewska","year":"1992","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB33","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0006-3223(99)00305-4","article-title":"Olanzapine increases allopregnanolone in the rat cerebral cortex","volume":"47","author":"Marx","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0006-3223(00)00955-0","article-title":"Altered salivary dehydroepiandrosterone levels in major depression in adults","volume":"48","author":"Michael","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0306-4522(01)00471-7","article-title":"Dehydroepiandosterone and its sulphate enhance memory retention in day-old chicks","volume":"109","author":"Migues","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00006842-200101000-00008","article-title":"Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa","volume":"63","author":"Monteleone","year":"2001","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"Depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB38","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1073\/pnas.94.14.7537","article-title":"Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone","volume":"94","author":"Morley","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0022-2143(98)90181-0","article-title":"Longitudinal changes in dehydroepiandrosterone concentrations in men and women","volume":"131","author":"Nafziger","year":"1998","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0924-977X(02)00077-9","article-title":"Clozapine decreases rat brain dehydroepiandrosterone and dehydroepiandrosterone sulfate levels","volume":"13","author":"Nechmad","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0447.1994.tb05867.x","article-title":"The vulnerability\/stress model of schizophrenic relapse: a longitudinal study","volume":"382","author":"Nuechterlein","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0306-4530(94)90017-5","article-title":"Serum gonadal steroid hormones in young schizophrenic patients","volume":"19","author":"Oades","year":"1994","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB43","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/BF01938331","article-title":"Interaction between dehydroepiandrosterone, cyclic adenosine-3\u2032,5\u2032-monophosphate and glucose-6-phosphate-dehydrogenase in normal and diseased subjects","volume":"30","author":"Oertel","year":"1974","journal-title":"Experientia"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB44","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1210\/jc.75.4.1002","article-title":"Long-term longitudinal measurements of plasma dehydro-epiandrosterone sulfate in normal men","volume":"75","author":"Orentreich","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB45","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1043-2760(02)00609-4","article-title":"Dissecting human adrenal androgen production","volume":"13","author":"Rainey","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-440X(95)90253-8","article-title":"The Talbieh Brief Distress Inventory: a brief instrument to measure psychological distress among immigrants","volume":"36","author":"Ritsner","year":"1995","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB46","doi-asserted-by":"crossref","first-page":"880","DOI":"10.4088\/JCP.v61n1113","article-title":"Differences in quality of life domains, psychopathologic and psychosocial factors in psychiatric patients","volume":"61","author":"Ritsner","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/comp.2002.30800","article-title":"Assessing psychological distress in psychiatric patients: validation of the Talbieh Brief Distress Inventory","volume":"43","author":"Ritsner","year":"2002","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-8993(87)90807-9","article-title":"Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice","volume":"406","author":"Roberts","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB50","first-page":"CR152","article-title":"Androgen and SHBG serum concentrations in late post-menopause women","volume":"9","author":"Skalba","year":"2003","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB51","unstructured":"Speilberger, C.D., 1977. Self-evaluation Questionnaire State Anxiety Inventory (STAI Form Y-1) STAIP-AD Test Form Y. Mind Garden."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB52","doi-asserted-by":"crossref","unstructured":"Speilberger, C.D., 1988. Self-evaluation Questionnaire State-Trait Anger Expression Inventory. Psychological Assessment Resources","DOI":"10.1037\/t29496-000"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB53","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1017\/S0033291799002731","article-title":"Elevated circulatory level of GABA(A)-antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder","volume":"30","author":"Spivak","year":"2000","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB54","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/eje.0.1450669","article-title":"Neurosteroid metabolism in the human brain","volume":"145","author":"Stoffel-Wagner","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB55","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s007020050077","article-title":"Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication","volume":"105","author":"Takebayashi","year":"1998","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB56","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jc.79.5.1273","article-title":"Serum dehydroepiandrosterone sulfate levels as an individual marker","volume":"79","author":"Thomas","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB57","first-page":"395","article-title":"Temporal variations in androgens and stress hormones in control and schizophrenic subjects","volume":"14","author":"Tourney","year":"1979","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB58","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archpsyc.1972.01750300025004","article-title":"Plasma androgens in male schizophrenics","volume":"27","author":"Tourney","year":"1972","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-002-1257-1","article-title":"Neurosteroids in depression: a review","volume":"165","author":"van Broekhoven","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0306-4530(01)00014-2","article-title":"Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation","volume":"26","author":"van Niekerk","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB61","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1210\/jcem-44-6-1222","article-title":"Effect of prolactin on plasma DHEA (s) levels","volume":"44","author":"Vermeulen","year":"1977","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB62","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1037\/0033-295X.104.4.667","article-title":"Schizophrenia: a neural diathesis-stress model","volume":"104","author":"Walker","year":"1997","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0014-2999(01)01383-8","article-title":"Treatment with dehydroepiandrosterone sulfate increases NMDA receptors in hippocampus and cortex","volume":"430","author":"Wen","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000285058","article-title":"Empirical assessment of the factorial structure of clinical symptoms in Schizophrenia","volume":"30","author":"White","year":"1997","journal-title":"Psychopathology"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB65","series-title":"Guidelines for ATC Classification and DDD assignment","year":"2000"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB66","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0165-0173(99)00021-1","article-title":"Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans","volume":"30","author":"Wolf","year":"1999","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB67","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.156.4.646","article-title":"Double-blind treatment of major depression with dehydroepiandrosterone","volume":"156","author":"Wolkowitz","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.09.003_BIB68","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1176\/appi.ajp.159.7.1237","article-title":"Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients","volume":"159","author":"Young","year":"2002","journal-title":"Am. J. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X03001871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X03001871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T14:28:18Z","timestamp":1682605698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X03001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0924977X03001871"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2003.09.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}